IGHG3 and COVID-19: Through broad characterization of the antibody landscape following COVID-19 vaccination, pregnancy was associated with reduced cross-reactive antibody responses, reflected in decreased IgG1:IgG3 ratios, nAb titers, and FcR binding in pregnant compared with non-pregnant women.